MYRIAD GENETICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
MYRIAD GENETICS, INC. (MYGN) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $20.38 per share as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2022-02-25
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $20.38.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $24.71.
- 2020-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $24.47.
- 2019-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $24.45.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2021-12-31 | $20.38 10-K · filed 2022-02-25 |
| 2020-12-31 | $24.71 10-KT · filed 2021-03-16 |
| 2020-06-30 | $24.47 10-K · filed 2020-08-13 |
| 2019-06-30 | $24.45 10-K · filed 2019-08-13 |
| 2018-06-30 | $24.50 10-K · filed 2018-08-24 |
| 2017-06-30 | $24.55 10-K · filed 2017-08-09 |
| 2016-06-30 | $24.04 10-K · filed 2016-08-10 |
| 2015-06-30 | $22.80 10-K · filed 2015-08-12 |
| 2014-06-30 | $21.90 10-K · filed 2014-08-13 |
| 2013-06-30 | $20.51 10-K · filed 2013-08-14 |
| 2012-06-30 | $18.01 10-K · filed 2012-08-15 |
| 2011-06-30 | $15.53 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |